Blog
First-Time-Right Formulation, Built with Full Lifecycle Intent
24 Feb 2026
en
Crystal Pharmatech provides integrated formulation development services for oral drug products, helping innovative biotech and pharmaceutical companies accelerate molecules from First-in-Human (FIH) studies to commercial manufacturing. Our First-Time-Right philosophy ensures robust bioavailability, scalable manufacturing, and regulatory readiness from day one.
Early shortcuts—such as powder-in-capsule or super placebo approaches—frequently result in costly downstream risks. Our approach eliminates these bottlenecks through integrated design and predictive modeling.
Traditional "fit-for-purpose" strategies often lead to the need for costly reformulation after Proof of Concept (POC).
Early shortcuts frequently result in bioavailability variability and additional human PK bridging studies with high costs.
We ensure scalable processes with a line of sight for late-stage development to prevent regulatory delays.
A well-designed formulation must balance desired bioavailability, stability, and a scalable manufacturing process. We create tailor-made designs for each molecule.
Combining leadership with deep expertise and state-of-the-art pilot plants to be your trusted partner for IND filings and beyond.
Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.
Our capabilities span three specialized platforms:
Small Molecule
Crystal Bio Solutions
Crystal NAX
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
Subscribe to be the first to get the updates!